Delivery Order W91YU015D0010-W81K0219F0018

Award Date 11/21/18
Potential Completion Date 9/30/19
Potential Value $539K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tacoma, WA 98431, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $27,500 firm fixed price call against the PANTHER STANDARD blanket purchase agreement to Gen-Probe Incorporated for one year of service. The contract has a period of performance from October 1, 2019 through September 30, 2020. Gen-Probe Sales & Service, Inc. will perform the work at the place of performance in Silver Spring, Maryland. No set-aside provisions were applied to this award to provide standard services in support of the Army...
The Department of the Army Medical Command awarded a $1.13 million firm fixed price delivery order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for PANTHER REAGENTS DO#2. The order, running from April 29, 2022 through September 30, 2022, is being funded by the Army Medical Command to provide reagents and related materials to support the Army's medical laboratory testing programs. Gen-Probe, headquartered in Marlborough, Massachusetts, will serve as the prime...
Gen-Probe Incorporated, through its division Gen-Probe Sales & Service, Inc., has been awarded a $543,750 firm fixed price delivery order contract by the Defense Health Agency to provide molecular analyzer systems, reagents, and associated supplies and services. Performance will occur at Madigan Army Medical Center in Washington through September 30, 2023. This delivery order was issued against an existing Indefinite Delivery Contract held by Gen-Probe, but details of the parent vehicle were...
The Department of the Army Medical Command awarded a $52,972.60 firm fixed price call against its PANTHER FUSION STANDARD blanket purchase agreement to Gen-Probe Incorporated on March 4, 2021. Performance will take place in Marlborough, Massachusetts through March 31, 2022. Gen-Probe Sales & Service, Inc. will deliver products or services in support of the Army Medical Command's medical equipment and supply needs. No set-aside provisions were specified for this particular call under the...
The Department of the Army Medical Command awarded Gen-Probe Incorporated, a medical diagnostics company, a $330,000.00 firm fixed price purchase order for the PANTHER INSTRUMENT SYSTEM. This contract is not set aside and is related to the Coronavirus COVID-19 national interest action. Gen-Probe Incorporated has previously provided a variety of medical testing systems and assays, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans...
Gen-Probe Incorporated, operating through its division Gen-Probe Sales & Service, Inc., has been awarded a $49,000 firm fixed price call against the PANTHER FUSION STANDARD SERVICE blanket purchase agreement by the Department of the Army Medical Command. Under this contract, Gen-Probe will provide maintenance and support services for two PANTHER FUSION diagnostic systems located in Marlborough, Massachusetts through March 2023. The PANTHER FUSION is an automated molecular diagnostic platform...
The Department of the Army Medical Command awarded a $1.125 million firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for the PANTHER FUSION SYSTEM. The contract is associated with responding to the Coronavirus COVID-19 national interest and will be performed at 2330 Stanley Rd, Fort Sam Houston, TX 78234. Under the contract, Gen-Probe will deliver its PANTHER FUSION SYSTEM platform to support the Army Medical Command's medical testing and...
Gen-Probe Incorporated, operating through its Gen-Probe Sales & Service division, has been awarded a $16.2 million firm fixed price delivery order contract by the Department of the Army Medical Command to provide COVID-19 PANTHER Fusion test kits. The test kits will support the Army's medical response to the coronavirus pandemic and will be delivered to a facility in Fort Sam Houston, Texas. No subcontractors or set aside designations were identified. The contract was funded under the Army's...
This is a delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for the provision of PANTHER SYSTEM REAGENTS. The contract is a Firm Fixed Price contract with a potential value of $288,636.32 and a completion date of September 30, 2022. The contract does not have a set-aside designation. Gen-Probe Incorporated has a history of providing a variety of medical diagnostic tests and equipment, such as assays for...
This federal contract award is for PANTHER EQUIPMENT AND TEST KITS, delivered by Gen-Probe Incorporated, a medical diagnostics company, to the U.S. Department of Defense's Medical Command. The $659,000.00 Firm Fixed Price Delivery Order contract has an ultimate completion date of September 30, 2020. Gen-Probe has held numerous federal contracts to provide medical diagnostic products and services, including molecular testing systems, assays, and supplies for detecting infectious diseases like...
  • W91YU015D0010
    Indefinite Delivery Contract
  • W91YU015D0010-W81K0219F0018
    Delivery Order

The Department of the Army Medical Command awarded a $539,000 firm fixed price delivery order contract to Gen-Probe Incorporated for PANTHER EQUIPMENT AND TEST KITS. Gen-Probe Sales & Service, Inc., a division of Gen-Probe Incorporated, will fulfill the contract. Performance will occur at Madigan Army Medical Center in Joint Base Lewis-McChord, Washington. The contract was awarded on November 21, 2018 under an indefinite-delivery/indefinite-quantity vehicle and has a completion date of September 30, 2019. No set-aside designation was used for this award from the Department of the Army Medical Command to Gen-Probe Incorporated for molecular diagnostic testing systems and assays in support of the agency's medical programs.

Generated 2/1/24, 10:21 AM